-
Providing affirming support to older LGBTQ+ adults could be one way to reduce their risk for dementia. These individuals face unique challenges compared to straight, cisgender seniors.
-
Six in 10 people living with the Alzheimer's disease will wander off at some point.
-
In a health care system that assumes older adults have family caregivers to help them, those facing dementia by themselves often fall through the cracks.
-
Verbal, physical, and sexual aggression among dementia patients in long-term care facilities are alarmingly common. “There is a real problem with endemic violence,” one researcher says.
-
FDA approval is required to make Alzheimer's biomarker testing affordable, but a brain specialist is needed to make an accurate diagnosis.
-
The disease requires a brain scan or spinal tap to spot one sticky amyloid protein. But a recent study finds that a certain blood test helped improve diagnosis without more costly follow-up procedures.
-
The GUIDE Model is designed to facilitate comprehensive, coordinated care that improves the quality of life for people with dementia and reduces the strain on their unpaid caregivers.
-
The FDA approved donanemab, which will be sold under the brand name Kisunla. The new drug helps slow decline in Alzheimer's patients with mild cognitive impairment.
-
A 2023 Alzheimer's Association report notes that 70% of caregivers say coordinating care is stressful. Three out of four say they are concerned for their own health given the stress and difficulty of the job.
-
A neurologist and neuropathologist address the prevalence, risk factors, early detection signs and preventive measures related to brain diseases.